ArticleFrontiers in immunology2020

Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses.

Amy Haseley Thorne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.